Background. Infants <6 months of age are too young to receive influenza vaccine, despite being at high risk for severe influenza-related complications.
Infants <6 months of age are too young to receive the influenza vaccine, despite being at high risk for severe influenza-related complications. In the United States, to protect these infants, influenza vaccination has been recommended for individuals who live with or care for these infants, particularly their mothers [1] . In addition, the World Health Organization issued a position paper recommending that pregnant women be accorded the highest priority for seasonal influenza vaccination, owing to expectations of vaccine effectiveness in preventing influenza in mothers and their infants [2] .
However, to our knowledge, only 7 studies have reported the effectiveness of maternal influenza vaccination for influenza in infants <6 months of age [3] [4] [5] [6] [7] [8] [9] . Moreover, these previous studies have reported inconsistent results. Four studies indicated significant vaccine effectiveness in preventing infant influenza and its related hospitalization [3] [4] [5] [6] , while the remaining 3 studies did not indicate any effectiveness of maternal influenza vaccination [7] [8] [9] . We believe there could be several possible reasons for this inconsistency. Since the previous studies focused on the effectiveness of vaccination of pregnant women, they might not have taken the possible effects of vaccination of postpartum women into consideration. Influenza vaccination of postpartum women may prevent influenza among mothers, which may contribute to protecting their infants from influenza. If, however, these postpartum-vaccinated women were classified as unvaccinated women, it would lead to underestimation of the effectiveness of maternal influenza vaccination. In addition, studies that used acute febrile respiratory illness rather than laboratory-confirmed influenza as a study outcome may have included noninfluenza cases, so that the resultant outcome misclassification would make it more difficult to detect vaccine effectiveness.
Thus, in the present prospective cohort study, which investigated the effectiveness of maternal influenza vaccination in preventing infant influenza and its related hospitalization, maternal influenza vaccination was divided into prenatal vaccination and postpartum vaccination in the detailed analysis, and the effectiveness of vaccination during each period was estimated separately. In addition, although we used pediatrician-diagnosed influenza as the main study outcome, we considered it an appropriate substitute for laboratory-confirmed influenza because the influenza rapid diagnostic test is routinely performed for infants who visit pediatric hospitals and clinics for medical treatment of acute febrile respiratory illnesses during the influenza season in Japan.
METHODS

Participants
This study was conducted with the cooperation of the 117 maternity hospitals and clinics affiliated with the Obstetrical Gynecological Society of Osaka, Japan. To enroll infants born at the collaborating hospitals and clinics before the start of the 2013-2014 influenza season, 10 720 pregnant women (regardless of gestational age) who were attending these hospitals and clinics between September 2013 and December 2013 were recruited to participate in the present study. At that time, 2812 women were in the first trimester, whereas 3585 and 4323 women were in the second and third trimesters, respectively. A total of 3841 infants were delivered by these women before the start of the 2013-2014 influenza season (ie, between October and December 2013) and were identified as study candidates. Mothers of the participating infants received an explanation of the study from their obstetrician and verbally provided informed consent prior to participation.
The study protocol was approved by the Ethics Committees at the Osaka City University Graduate School of Medicine and was performed in accordance with the Declaration of Helsinki.
Information Collection
At the time of recruitment, data on the following maternal characteristics were obtained by means of a self-administered questionnaire completed by each infant's mother: maternal age, height and weight before pregnancy, underlying illnesses, and influenza vaccination status for the 2013-2014 season.
With respect to the follow-up survey conducted after the 2013-2014 influenza season (ie, May 2014), the mothers were asked to fill out a mail-back questionnaire to collect the following information that had become available since the time of recruitment: for infants, the date and gestational week of birth, birth weight, daycare attendance, influenza diagnosis made by a pediatrician, and hospitalization; and for mothers, influenza vaccination history after recruitment and influenza diagnosis. Mothers of infants who had been hospitalized were also asked to provide the name of the disease that led to hospitalization and the name of the hospital. To confirm this self-reported information on hospitalization, we contacted the pediatricians at the relevant hospitals and asked them to provide the following information from the subject's hospital records: date of admission, date of discharge, name of disease that led to hospitalization, and laboratory data at the time of hospitalization.
In addition, to obtain clinical information about the infants' birth, the obstetrician caring for their mothers was asked to complete a structured questionnaire. The questionnaire gathered information about the infants' date and gestational week of birth, birth weight, presence of congenital malformation, and birth order (ie, the mother's parity status when the infant was delivered).
Statistical Analysis
As an exposure variable, the effect of maternal influenza vaccination was first investigated after categorizing mothers as unvaccinated or receiving vaccination and then after categorizing them as unvaccinated, receiving prenatal vaccination, or receiving postpartum vaccination.
The following 2 outcome measures for infants were used in the present study: pediatrician-diagnosed influenza and hospitalization due to an influenza diagnosis.
With regard to explanatory variables, maternal age was categorized as <29, 30-34, and ≥35 years. The following maternal influenza-related underlying conditions, based on a previous report, were included: chronic respiratory disorders (including asthma), cardiovascular disorders (excluding isolated hypertension), kidney disease, liver disease, neurological disorders, blood disorders, metabolic disorders (including diabetes), immunocompromised state (due to factors such as malignant tumors, connective tissue disorders, inflammatory bowel disease, and chronic rheumatism), and obesity (ie, a body mass index [calculated as the weight in kilograms divided by the height in meters squared] of ≥25.0) [1] . Data regarding the number of siblings of the infants were based on the mother's parity status recorded during the obstetrician-administered questionnaire.
A logistic regression model was used to calculate the odds ratio (OR) and 95% confidence interval (CI) for the associations between maternal influenza vaccination and the outcome measures. In the multivariate model, we included all variables in the univariate analyses that were related to both maternal vaccination status (ie, the exposure variable) and infant influenza diagnosis (ie, the outcome index) with P values of <.10. Furthermore, stratified analysis was conducted to examine whether the effectiveness of maternal influenza vaccination against influenza acquisition by their infants varied according to the maternal influenza diagnostic status in the relevant season. The χ 2 and Wilcoxon rank-sum tests were also used where appropriate. All analyses were 2-tailed and were conducted using SAS, version 9.3.
RESULTS
Among 3841 infants, incomplete data on the variables under study caused the exclusion of 400 infants, leaving 3441 infants (89.6%) for analysis. Table 1 shows the characteristics of the study infants and their mothers. Median maternal age was 32 years, and 22% of mothers had influenza-related underlying conditions. A total of 39% of mothers received the influenza vaccine for the 2013-2014 season, and 27% were vaccinated during their pregnancy. A total of 5% of study infants were born prematurely, whereas 9% had a low birth weight. Approximately half the infants had older siblings, and 8% began attending daycare facilities in the 2013-2014 season. Table 2 shows the association between maternal influenza vaccination and select background characteristics. Unvaccinated mothers were younger than vaccinated mothers. In addition, infants' birth month appeared to affect the timing of maternal vaccination (ie, during the prenatal or postpartum periods).
Preterm birth, low birth weight, and congenital malformations were more often observed in infants delivered by unvaccinated mothers. Vaccinated mothers were likely to be multipara, suggesting that their infants had at least 1 older sibling.
During the 2013-2014 influenza season, 71 infants (2%) had influenza diagnosed (Table 3 ). Univariate analysis revealed that maternal influenza vaccination had a decreasing effect on the occurrence of pediatrician-diagnosed influenza among infants. The proportion of infants with an influenza diagnosis was also lower among those born in December or with a low birth weight. On the other hand, maternal influenza diagnosis, presence of older siblings, and daycare attendance were associated with a higher risk of influenza among infants. Even after considering the effects of these potential confounding factors, maternal vaccination showed a decreasing OR for an influenza diagnosis among infants (OR, 0.42; 95% CI, .22-.78). In particular, prenatal vaccination was associated with a statistically significantly lower OR of 0.39 (95% CI, .19-.84). Although postpartum vaccination also showed a decreasing OR for influenza among infants, it did not reach statistically significant levels, owing to the limited number of study subjects. Conversely, a diagnosis of maternal influenza elevated the OR for a diagnosis of influenza in infants by 36-fold, implicating influenza in mothers as a strong risk factor for influenza virus infection in infants. In addition, the presence of older siblings or daycare attendance also increased the ORs for influenza among infants by approximately 2-3-fold. Table 4 shows the association between infant hospitalization due to influenza and background characteristics, including maternal vaccination. In multivariate analysis, maternal vaccination decreased the OR for infant hospitalization due to influenza by approximately one fourth, with marginal statistical significance (OR, 0.27; 95% CI, .06-1.24). The OR of prenatal vaccination was also decreased to 0.33, which, however, was not statistically significant. We could not calculate the OR of postpartum vaccination, since there were no hospitalized cases in this category. On the other hand, maternal influenza was associated with a higher risk of infant hospitalization due to influenza, while a greater number of older siblings was also associated with an elevated OR for infant hospitalization. The ORs for these variables were 13.8 (95% CI, 4.42-42.9) and 6.88 (95% CI, 1.27-37.3), respectively.
The effect of maternal influenza vaccination was examined in terms of the status of maternal influenza diagnosis in the 2013-2014 season (Table 5) . Among mothers with a diagnosis of influenza in the 2013-2014 season, the proportion of infants with influenza was 33% for unvaccinated mothers, 16% for those with a prenatal vaccination, and 16% for those with a postpartum vaccination. Among mothers without a diagnosis of influenza, the proportions of infants with influenza were much smaller (1% for unvaccinated mothers, 0.4% for those with a prenatal vaccination, and 0.8% for those with a postpartum vaccination). Attends daycare 260 (8) However, the ORs of maternal influenza vaccination were quite similar regardless of whether the mothers received a diagnosis of influenza. Regarding infant hospitalization due to influenza, stratified analysis could not provide meaningful results, since the number of infants hospitalized due to influenza was very limited.
DISCUSSION
The findings of the present study demonstrated that maternal influenza vaccination decreases the occurrence of influenza and its related hospitalization in their infants. Among infants, the vaccine effectiveness of maternal influenza vaccination was 58% (95% CI, 22%-78%) for pediatrician-diagnosed influenza and 73% (95% CI, −24%-94%) for influenza-related hospitalization. These results are consistent with those of previous studies conducted in other countries [3] [4] [5] [6] . When we examined the effects of maternal vaccination by dividing it into prenatal vaccination and postpartum vaccination, prenatal vaccination seemed to be more effective in preventing influenza infection in infants; the effectiveness of prenatal vaccination for infants' pediatrician-diagnosed influenza was 61% (95% CI, 16%-81%) and that of postpartum vaccination was 53% (95% CI, −28%-83%). However, we did not conclude that postpartum vaccination had no effect on infant influenza, because the effectiveness of postpartum vaccination was 53% (point estimate) and the number of study subjects with postpartum vaccination was really smaller than the number of those with prenatal vaccination. It is therefore possible that the lack of statistical significance in the effectiveness of postpartum vaccination might have resulted from the lack of statistical power in our study.
There are 2 possible mechanisms for the observed effect of maternal influenza vaccination on decreasing the risk of influenza among infants. The first is through passive immunity, in which maternal antibodies produced in response to prenatal vaccination are transferred to the fetus via the umbilical cord and, thus, protect the infant from contracting influenza. Previous studies have reported this possibility by showing the presence of passive antibodies in umbilical cords and serum samples from infants [10] [11] [12] [13] . The second mechanism is that vaccinated mothers have a lower risk of developing influenza, which secondarily results in a reduced risk of influenza among infants. In theory, since prenatal vaccination could have both of these effects and postpartum vaccination only includes the latter mechanism, the difference between the effectiveness of prenatal and postpartum vaccination is probably the effect of passive immunity. From this point of view, the effect of passive immunity could be calculated as only 8%, and the remaining 53% might be explained by the latter mechanism. Hence, prenatal vaccination is expected to be more effective for preventing influenza in infants because it exerts effects through both mechanisms described above. Prenatal vaccination is therefore considered preferable for preventing influenza among infants, although if mothers do not receive influenza vaccination during pregnancy, postpartum vaccination would also be useful in protecting their infants from the threat of influenza. The present study also showed strong associations between an influenza diagnosis among infants and the presence of influenza in their mothers, the presence of older siblings, and attendance at a daycare facility. In particular, the risk of an influenza diagnosis among infants with mothers who had influenza was 36 times the risk among infants without mothers who had influenza. In general, younger infants, especially those aged <6 months, tend to be kept inside the house during winter; therefore, household members are usually the primary source of influenza virus infection among infants. Mothers in particular tend to have the most contact with infants because they are usually their main caregivers. Hence, if a mother is infected with influenza virus, it is often easily transmitted to their infant. Infants can also be exposed to influenza virus in the daycare setting. Therefore, to protect infants <6 months of age who are too young to be vaccinated, family members living in the same household (particularly mothers) should receive influenza vaccine; the stratified analysis in the present study supported this recommendation by also showing the protective effect of maternal influenza vaccination against influenza among infants whose mothers received a diagnosis of influenza. And if family members contract influenza, protective measures, such as wearing masks and putting some distance between infected family members and the infant, should be taken to avoid transmission to the infant. In the present study, infants born in December and those with low a birth weight had a lower risk of influenza. These findings are unexpected but might be explained by the possibility that a decreased opportunity for contact with influenza virus results in a lower odds of contracting influenza. Specifically, during the influenza season, infants born in December are younger than those born in October and, thus, have a greater likelihood of remaining indoors in the winter. In addition, because infants with a low birth weight are usually treated in incubators until they reach an adequate weight, they may have spent less time at home during the influenza season than those with a normal or higher birth weight. However, we cannot confirm whether this explanation is accurate, since we did not obtain any information on the frequency of leaving home and the date of hospital discharge after birth. In addition, infants born in December had an increased odds of hospitalization, although the association was not statistically significant. Thus, it seems sensible to have reservations about a relationship between birth month and influenza risk among infants. The present study has the following advantages. First, this is the first study to investigate the effects of maternal vaccination on influenza among infants by using a large cohort of infants (>3000). This enabled us to examine not only the effects of maternal vaccination, but also that of prenatal versus postpartum vaccination, which further helps to elucidate the mechanisms of protective effects of maternal influenza vaccination against influenza among infants. Second, while information on infant hospitalization relied on self-reported data from mothers, the accuracy of the data was ensured by contacting the relevant admitting hospital. Although we were able to obtain information from hospital records for only 54% of infants reported to be hospitalized, almost all information obtained from mothers about the admission date and name of the disease leading to hospitalization was identical to the data from the hospital records. Thus, we believe that the self-reported information about infant hospitalization was reliable. Third, since all study subjects were recruited from within Osaka Prefecture, characteristics of the subjects' exposure to influenza viruses were considered to be similar.
However, this study also had some limitations. First, there may have been some misclassification of infants' influenza diagnoses. However, in Japan, since rapid diagnostic tests are conventionally used in the clinical setting, almost all reports of infant influenza would be expected to be based on the results of rapid tests. On the other hand, the infants' influenza diagnoses would be affected by their mothers' attitudes toward seeking medical attention. For example, febrile infants observed at home without visiting a medical facility may have been classified as not having influenza even if they had contracted the virus. However, since infants were as young as several months olds, most mothers would have taken their infants to the hospital or clinic if they had a fever. Thus, the number of misclassifications of infants' influenza diagnoses, if any, would be expected to be low, compared with the studies targeting older infants. Second, generally speaking, since vaccinated mothers have a higher level of health consciousness than unvaccinated mothers, they might avoid taking their infants outside in the influenza season. If this behavior was different between vaccinated and unvaccinated mothers, the observed vaccine effectiveness in the present study might be biased toward overestimation. Third, since the infants in the present study were all born at obstetric facilities in Osaka Prefecture before the beginning of the 2013-2014 influenza season, there is some concern about the generalizability of the results. Further investigation in different seasons and regions is desirable to confirm the validity of the findings in the present study.
In conclusion, these results indicate that maternal vaccination could protect infants from contracting influenza. Pregnant women should receive influenza vaccination to protect not only themselves but also their infants. If they do not receive influenza vaccination during pregnancy, postpartum vaccination would also be useful in protecting their infants from the threat of influenza.
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